Core Scientific officer sells 10,000 shares

Core Scientific, Inc. reported that officer Todd M. Duchene sold a total of 10,000 shares of common stock in the open market on June 8, 2026.

Rhea-AI Filing Summary

Core Scientific, Inc. reported that officer Todd M. Duchene sold a total of 10,000 shares of common stock in the open market on June 8, 2026. The sales occurred in two blocks: 4,500 shares at a weighted average price of $27.1053 per share and 5,500 shares at a weighted average price of $26.6376 per share.

The filing notes that these transactions were executed under a pre-established Rule 10b5-1 trading plan adopted on December 5, 2025, meaning the trades were pre-arranged rather than timed at the officer’s discretion.

Insider Trade Summary 10b5-1

Net Seller: 10,000 shares

Net Sell 2 txns

Insider DUCHENE TODD M

Role See remarks

Sold 10,000 shs ($268K)

Type	Security	Shares	Price	Value
Sale	Common Stock	5,500	$26.6376	$147K
Sale	Common Stock	4,500	$27.1053	$122K

Holdings After Transaction: Common Stock — 2,068,895 shares (Direct)

Footnotes (3)

1. F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
2. F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.96 to $26.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
3. F3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.97 to $27.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Key Figures

Shares sold: 10,000 shares First block sale price: $27.1053 per share First block size: 4,500 shares +2 more

5 metrics

Shares sold 10,000 shares Total common stock sold by officer on June 8, 2026

First block sale price $27.1053 per share Weighted average price for 4,500-share sale

First block size 4,500 shares Common stock sold in first transaction

Second block sale price $26.6376 per share Weighted average price for 5,500-share sale

Second block size 5,500 shares Common stock sold in second transaction

Key Terms

Rule 10b5-1 trading plan, weighted average price, open-market sale, non-derivative, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported is a weighted average price. These shares were sold in multiple transactions"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

non-derivative financial

"transaction_type: non-derivative"

Form 4 regulatory

"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Core Scientific (CORZ) report for Todd M. Duchene?

Core Scientific reported that officer Todd M. Duchene sold 10,000 shares of common stock. The sales were disclosed in a Form 4 filing and represent routine open-market transactions executed under a pre-arranged Rule 10b5-1 trading plan.

How many Core Scientific (CORZ) shares did Todd M. Duchene sell and on what date?

Todd M. Duchene sold a total of 10,000 Core Scientific common shares on June 8, 2026. The Form 4 shows two separate open-market sale transactions completed on that same date pursuant to his trading plan.

At what prices were Todd M. Duchene’s Core Scientific (CORZ) shares sold?

The filing reports 4,500 shares sold at a weighted average price of $27.1053 and 5,500 shares sold at a weighted average price of $26.6376. Each line reflects multiple trades within stated intraday price ranges.

Were Todd M. Duchene’s Core Scientific (CORZ) stock sales under a Rule 10b5-1 plan?

Yes. The Form 4 specifies that all reported transactions were executed under a Rule 10b5-1 trading plan adopted on December 5, 2025. Such plans pre-schedule trades, reducing the role of day-to-day discretion in timing.

What type of transaction code appears in Todd M. Duchene’s Core Scientific (CORZ) Form 4?

Both entries use transaction code “S,” indicating open-market or private sale of common stock. The transactions are classified as non-derivative, meaning they involve direct common shares rather than options or other derivatives.

Does Todd M. Duchene’s Form 4 involve any options or derivative securities of Core Scientific (CORZ)?

No. The reported transactions cover only non-derivative common stock. The derivative section shows no option exercises or other derivative trades, indicating this filing reflects straightforward share sales rather than option-related activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/10/2026 - 04:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DUCHENE TODD M

(Last) (First) (Middle)

C/O CORE SCIENTIFIC, INC.

838 WALKER ROAD, SUITE 21-2105

(Street)

DOVER DELAWARE 19904

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Core Scientific, Inc./tx [ CORZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/08/2026		S(1)		5,500	D	$26.6376(2)	2,073,395	D
Common Stock	06/08/2026		S(1)		4,500	D	$27.1053(3)	2,068,895	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.96 to $26.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.97 to $27.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Remarks:

Chief Legal and Administrative Officer

	/s/ Todd DuChene	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)